Vimarsana
Biggest News Aggregation in the World

Page 22 - Wave Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wave Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wave Life Sciences Today - Breaking & Trending Today

Apellis abandons ALS drug after study miss - Vimarsana News

Apellis abandons ALS drug after study miss

BioPharma

Wave Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Recommendation of "Moderate Buy" by Analysts - Vimarsana News

Wave Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Get Rating) have been given an average recommendation of “Moderate Buy” by the six research firms that are covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average […]

Peter Kolchinsky-led RA Capital's New Positions Feature CureVac, Mineralys, Pilant, Enliven Therapeu – 24/7 Wall St. - Vimarsana News

Peter Kolchinsky-led RA Capital's New Positions Feature CureVac, Mineralys, Pilant, Enliven Therapeu – 24/7 Wall St.

RA Capital's latest quarterly 13F fund update showcases new positions in the multistage healthcare and life science-focused fund.

Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia - Vimarsana News

Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Potent and durable target engagement observed across cohorts, including with 10 mg doses administered every 12 weeks which were also generally safe and well-tolerated WVE-004 did not show clinical... | May 23, 2023

Wave shelves ALS drug following trial setback - Vimarsana News

Wave shelves ALS drug following trial setback

BioPharma